174 related articles for article (PubMed ID: 32494162)
61. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
[TBL] [Abstract][Full Text] [Related]
62. Diosbulbin B induced G
Yang R; Wei M; Yang F; Sheng Y; Ji L
Toxicol Appl Pharmacol; 2018 Oct; 357():1-9. PubMed ID: 30145177
[TBL] [Abstract][Full Text] [Related]
63. Natural Steroidal Lactone Induces G1/S Phase Cell Cycle Arrest and Intrinsic Apoptotic Pathway by Up-Regulating Tumor Suppressive miRNA in Triple-Negative Breast Cancer Cells.
Shuaib M; Prajapati KS; Gupta S; Kumar S
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676955
[TBL] [Abstract][Full Text] [Related]
64. Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.
Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
Oncol Lett; 2019 Oct; 18(4):3837-3844. PubMed ID: 31579087
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
Guan X; Gu S; Yuan M; Zheng X; Wu J
Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
[TBL] [Abstract][Full Text] [Related]
66. LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple-negative breast cancer by sponging miR-6504-5p and miR-3139.
Luo X; Wang H
Cancer Cell Int; 2021 Mar; 21(1):180. PubMed ID: 33757509
[TBL] [Abstract][Full Text] [Related]
67. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
Wang Z; Wang X
J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
[TBL] [Abstract][Full Text] [Related]
68. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer.
Ma S; Wei H; Wang C; Han J; Chen X; Li Y
Cell Mol Biol Lett; 2021 Dec; 26(1):52. PubMed ID: 34895159
[TBL] [Abstract][Full Text] [Related]
69. Investigation of miR-93-5p and its effect on the radiosensitivity of breast cancer.
Pan C; Sun G; Sha M; Wang P; Gu Y; Ni Q
Cell Cycle; 2021 Jun; 20(12):1173-1180. PubMed ID: 34024254
[TBL] [Abstract][Full Text] [Related]
70. Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis.
Yang W; Gong P; Yang Y; Yang C; Yang B; Ren L
Cancer Manag Res; 2020; 12():2327-2337. PubMed ID: 32273769
[TBL] [Abstract][Full Text] [Related]
71. Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways.
Wang P; Song D; Wan D; Li L; Mei W; Li X; Han L; Zhu X; Yang L; Cai Y; Zhang R
PeerJ; 2020; 8():e9281. PubMed ID: 32547883
[TBL] [Abstract][Full Text] [Related]
72. A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy.
Liu Y; Hong G; Mao L; Su Z; Liu T; Liu H
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175072
[TBL] [Abstract][Full Text] [Related]
73. lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis.
Wang SM; Pang J; Zhang KJ; Zhou ZY; Chen FY
Mol Ther Oncolytics; 2021 Jun; 21():62-73. PubMed ID: 33869743
[TBL] [Abstract][Full Text] [Related]
74. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
75. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
Xu Y; Fang R; Shao J; Cai Z
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307
[TBL] [Abstract][Full Text] [Related]
76. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
De Blasio A; Di Fiore R; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Scerri C; Vento R; Tesoriere G
J Cell Physiol; 2020 Feb; 235(2):629-637. PubMed ID: 31313842
[TBL] [Abstract][Full Text] [Related]
77. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
Liu G; Wang P; Zhang H
J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
79. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis.
Liu C; Jiang F; Zhang X; Xu X
Cancer Manag Res; 2020; 12():2777-2788. PubMed ID: 32425595
[TBL] [Abstract][Full Text] [Related]
80. miR-515-5p inhibits the proliferation, migration and invasion of human breast cancer cells by targeting CBX4.
Wen LJ; Wang YS; Tan PY
Exp Ther Med; 2021 Nov; 22(5):1328. PubMed ID: 34630682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
